Nov 18, 2011 18:34 EST
(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.
Jun 15, 2011 16:31 EDT
WASHINGTON (Reuters) - A proposed eye medicine from Regeneron Pharmaceuticals and Bayer AG was found by U.S. drug reviewers to be an effective way of treating vision loss from macular degeneration, raising expectations it will be recommended for approval.
Oct 12, 2009 12:18 EDT
UBS analyst boosts price target for Amgen stock, citing osteoporosis drug, stable business. A UBS analyst on Monday boosted his price target on Amgen Inc., saying the launch of the company's osteoporosis drug denosumab should drive the stock's value.